These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12415632)

  • 1. Effect of thalidomide in different tumors in rodents.
    Palencia G; Arrieta O; Ríos C; Altagracia M; Kravzov J; Sotelo J
    J Exp Ther Oncol; 2002; 2(3):158-62. PubMed ID: 12415632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma.
    Arrieta O; Guevara P; Tamariz J; Rembao D; Rivera E; Sotelo J
    Int J Exp Pathol; 2002 Apr; 83(2):99-104. PubMed ID: 12084046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical effect of aspirin on the growth of C6 rat glioma and on time of development of ENU-induced tumors of the nervous system.
    Arrieta O; Guevara P; Reyes S; Palencia G; Rivera E; Sotelo J
    J Cancer Res Clin Oncol; 2001 Nov; 127(11):681-6. PubMed ID: 11710598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of thalidomide on DMBA-induced oral carcinogenesis in hamster with respect to angiogenesis.
    Yang Y; Ge JP; Zhou ZT
    J Oral Pathol Med; 2009 May; 38(5):455-62. PubMed ID: 19141066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas.
    Fine HA; Figg WD; Jaeckle K; Wen PY; Kyritsis AP; Loeffler JS; Levin VA; Black PM; Kaplan R; Pluda JM; Yung WK
    J Clin Oncol; 2000 Feb; 18(4):708-15. PubMed ID: 10673511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiogenesis and anti-angiogenic strategies for glioblastoma].
    de Boüard S; Guillamo JS
    Bull Cancer; 2005 Apr; 92(4):360-72. PubMed ID: 15888393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-alpha2b and thalidomide synergistically inhibit tumor-induced angiogenesis.
    Bauer JA; Morrison BH; Grane RW; Jacobs BS; Borden EC; Lindner DJ
    J Interferon Cytokine Res; 2003 Jan; 23(1):3-10. PubMed ID: 12639293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide prolongs disease stabilization after conventional therapy in patients with recurrent glioblastoma.
    Morabito A; Fanelli M; Carillio G; Gattuso D; Sarmiento R; Gasparini G
    Oncol Rep; 2004 Jan; 11(1):93-5. PubMed ID: 14654909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan cells and angiogenesis in vivo.
    Lentzsch S; LeBlanc R; Podar K; Davies F; Lin B; Hideshima T; Catley L; Stirling DI; Anderson KC
    Leukemia; 2003 Jan; 17(1):41-4. PubMed ID: 12529658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model.
    Murphy S; Davey RA; Gu XQ; Haywood MC; McCann LA; Mather LE; Boyle FM
    J Neurooncol; 2007 Nov; 85(2):181-9. PubMed ID: 17534579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of thalidomide on tumor growth in mouse hepatoma H22 model].
    Zhai Y; Lu ZJ
    Ai Zheng; 2003 Dec; 22(12):1301-6. PubMed ID: 14693056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme.
    Turner CD; Chi S; Marcus KJ; MacDonald T; Packer RJ; Poussaint TY; Vajapeyam S; Ullrich N; Goumnerova LC; Scott RM; Briody C; Chordas C; Zimmerman MA; Kieran MW
    J Neurooncol; 2007 Mar; 82(1):95-101. PubMed ID: 17031553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of thalidomide in patients with brain metastases from malignant melanoma.
    Vestermark LW; Larsen S; Lindeløv B; Bastholt L
    Acta Oncol; 2008; 47(8):1526-30. PubMed ID: 18607876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo.
    Gutman M; Szold A; Ravid A; Lazauskas T; Merimsky O; Klausner JM
    Anticancer Res; 1996; 16(6B):3673-7. PubMed ID: 9042240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma.
    Myoung H; Hong SD; Kim YY; Hong SP; Kim MJ
    Cancer Lett; 2001 Feb; 163(2):191-200. PubMed ID: 11165754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme.
    Marx GM; Pavlakis N; McCowatt S; Boyle FM; Levi JA; Bell DR; Cook R; Biggs M; Little N; Wheeler HR
    J Neurooncol; 2001 Aug; 54(1):31-8. PubMed ID: 11763420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular encapsulation of thalidomide with sulfobutyl ether-7 beta-cyclodextrin for immediate release property: enhanced in vivo antitumor and antiangiogenesis efficacy in mice.
    Kale R; Tayade P; Saraf M; Juvekar A
    Drug Dev Ind Pharm; 2008 Feb; 34(2):149-56. PubMed ID: 18302033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy in intracerebrally transplanted tumors induced with transplacental administration of ethylnitrosourea in rats.
    Mennel HD; Hellwig D; Simon H
    J Cancer Res Clin Oncol; 1986; 112(3):240-4. PubMed ID: 3782262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic agent, thalidomide increases the antitumor effect of single high dose irradiation (gamma knife radiosurgery) in the rat orthotopic glioma model.
    Lee JI; Itasaka S; Kim JT; Nam DH
    Oncol Rep; 2006 May; 15(5):1163-8. PubMed ID: 16596180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model.
    Son MJ; Kim JS; Kim MH; Song HS; Kim JT; Kim H; Shin T; Jeon HJ; Lee DS; Park SY; Kim YJ; Kim JH; Nam DH
    Int J Oncol; 2006 Jan; 28(1):53-9. PubMed ID: 16327979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.